Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Ibuleve 5% spray
1003020P0BCACAD
|
Ibuleve | Ibuprofen | Musculoskeletal and Joint Diseases | No data available |
|
Ibuleve Sports 5% gel
1003020P0BCABAC
|
Ibuleve | Ibuprofen | Musculoskeletal and Joint Diseases | No data available |
|
Ibumousse 5%
1003020P0BKAAAF
|
Ibumousse | Ibuprofen | Musculoskeletal and Joint Diseases | No data available |
|
Ibuprofen 200mg / Phenylephrine 6.1mg tablets
1001010J0AABSBS
|
Ibuprofen (NSAID) | Ibuprofen | Musculoskeletal and Joint Diseases | No data available |
|
Ibuprofen 200mg effervescent tablets
1001010J0AABPBP
|
Ibuprofen (NSAID) | Ibuprofen | Musculoskeletal and Joint Diseases | No data available |
|
Ibuprofen 300mg modified-release / Codeine 20mg tablets
1001010J0AAARAR
|
Ibuprofen (NSAID) | Ibuprofen | Musculoskeletal and Joint Diseases | No data available |
|
Ibuprofen 5% cream
1003020P0AAAAAA
|
Ibuprofen (Topical Antirheumatic) | Ibuprofen | Musculoskeletal and Joint Diseases | No data available |
|
Ibuprofen 5% foam
1003020P0AAAFAF
|
Ibuprofen (Topical Antirheumatic) | Ibuprofen | Musculoskeletal and Joint Diseases | No data available |
|
Ibuprofen 800mg tablets
1001010J0AAAGAG
|
Ibuprofen (NSAID) | Ibuprofen | Musculoskeletal and Joint Diseases | No data available |
|
Ibuprofen lysine 400mg oral powder sachets
1001010ADAAADAD
|
Ibuprofen lysine | Ibuprofen lysine | Musculoskeletal and Joint Diseases | No data available |
|
Ibutop Ralgex Ibuprofen 5% gel
1003020P0BIAAAC
|
Ralgex (Ibuprofen) | Ibuprofen | Musculoskeletal and Joint Diseases | No data available |
|
Idacio 40mg/0.8ml solution for injection pre-filled pens
1001030S0BGABAB
|
Idacio | Adalimumab | Musculoskeletal and Joint Diseases | No data available |
|
Idacio 40mg/0.8ml solution for injection pre-filled syringes
1001030S0BGACAA
|
Idacio | Adalimumab | Musculoskeletal and Joint Diseases | No data available |
|
Idacio 40mg/0.8ml solution for injection vials
1001030S0BGAAAC
|
Idacio | Adalimumab | Musculoskeletal and Joint Diseases | No data available |
|
Imraldi 40mg/0.4ml inj pre-filled syringes
1001030S0BFADAE
|
Imraldi | Adalimumab | Musculoskeletal and Joint Diseases | No data available |
|
Imraldi 40mg/0.4ml solution for injection pre-filled pens
1001030S0BFACAD
|
Imraldi | Adalimumab | Musculoskeletal and Joint Diseases | No data available |
|
Imraldi 40mg/0.8ml inj pre-filled syringes
1001030S0BFABAA
|
Imraldi | Adalimumab | Musculoskeletal and Joint Diseases | No data available |
|
Indocid 25mg capsules
1001010K0BDAAAA
|
Indocid | Indometacin | Musculoskeletal and Joint Diseases | No data available |
|
Indocid 50mg capsules
1001010K0BDABAB
|
Indocid | Indometacin | Musculoskeletal and Joint Diseases | No data available |
|
Indocid 5mg/ml oral suspension
1001010K0BDACAE
|
Indocid | Indometacin | Musculoskeletal and Joint Diseases | No data available |
|
Indocid R 75mg capsules
1001010K0BDAFAD
|
Indocid | Indometacin | Musculoskeletal and Joint Diseases | No data available |
|
Indolar SR 75mg capsules
1001010K0BGADAD
|
Indolar | Indometacin | Musculoskeletal and Joint Diseases | No data available |
|
Indomax 75 SR capsules
1001010K0BQABAD
|
Indomax | Indometacin | Musculoskeletal and Joint Diseases | No data available |
|
Indometacin 1.2mg/5ml oral liquid
1001010K0AAATAT
|
Indometacin (Systemic) | Indometacin | Musculoskeletal and Joint Diseases | No data available |
|
Indometacin 12mg/5ml oral liquid
1001010K0AAAYAY
|
Indometacin (Systemic) | Indometacin | Musculoskeletal and Joint Diseases | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.